Association of soluble Flt-1 with heart failure and cardiac morphology: The MESA angiogenesis study.

[1]  V. Salomaa,et al.  High-Sensitivity Cardiac Troponin I Levels and Prediction of Heart Failure: Results From the BiomarCaRE Consortium. , 2020, JACC. Heart failure.

[2]  K. Sliwa,et al.  Sex differences in heart failure. , 2019, European heart journal.

[3]  V. Morea,et al.  Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1 , 2018, International journal of molecular sciences.

[4]  C. Yancy,et al.  Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association , 2017, Circulation.

[5]  B. Westerhof,et al.  The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension. , 2017, Journal of the American College of Cardiology.

[6]  Jana A. Hirsch,et al.  The Impact of Neighborhoods on CV Risk. , 2016, Global heart.

[7]  S. Solomon,et al.  Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death. , 2016, JAMA cardiology.

[8]  M. Rousseau,et al.  Sflt-1 in heart failure: relation with disease severity and biomarkers , 2016, Scandinavian journal of clinical and laboratory investigation.

[9]  G. Ewald,et al.  Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study. , 2016, JACC. Heart failure.

[10]  John Eng,et al.  Adverse Left Ventricular Remodeling and Age Assessed with Cardiac MR Imaging: The Multi-Ethnic Study of Atherosclerosis. , 2016, Radiology.

[11]  J. Butler,et al.  Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure , 2016, Circulation. Heart failure.

[12]  George Davey-Smith,et al.  Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association , 2015, Circulation.

[13]  G. Breithardt,et al.  Soluble Flt-1 links microvascular disease with heart failure in CKD , 2015, Basic Research in Cardiology.

[14]  L. Maier,et al.  Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure. , 2014, Biomarkers in medicine.

[15]  B. French,et al.  Biomarker predictors of cardiac hospitalization in chronic heart failure: a recurrent event analysis. , 2014, Journal of cardiac failure.

[16]  B. French,et al.  Heart Failure With Recovered Ejection Fraction: Clinical Description, Biomarkers, and Outcomes , 2014, Circulation.

[17]  Randolph P. Martin,et al.  Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab. , 2014, Journal of the American College of Cardiology.

[18]  M. Shibuya,et al.  Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. , 2013, Journal of biochemistry.

[19]  A. Praestgaard,et al.  Right Ventricular Structure Is Associated With the Risk of Heart Failure and Cardiovascular Death: The Multi-Ethnic Study of Atherosclerosis (MESA)-Right Ventricle Study , 2012, Circulation.

[20]  John Mitchell,et al.  Cardiac Angiogenic Imbalance Leads to Peri-partum Cardiomyopathy , 2012, Nature.

[21]  W. Gaasch,et al.  Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry. , 2011, Journal of the American College of Cardiology.

[22]  K. Ruparel,et al.  The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure. , 2011, Journal of the American College of Cardiology.

[23]  P. D. del Nido,et al.  Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium. , 2011, Cardiovascular research.

[24]  David A Bluemke,et al.  The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. , 2008, Journal of the American College of Cardiology.

[25]  K. Sliwa,et al.  A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy , 2007, Cell.

[26]  S. Lai,et al.  Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. , 2006, AJR. American journal of roentgenology.

[27]  Adrian G Barnett,et al.  Regression to the mean: what it is and how to deal with it. , 2004, International journal of epidemiology.

[28]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[29]  D. Herpin,et al.  Effect of regression to the mean in serial echocardiographic measurements of left ventricular mass. Quantification and clinical implications. , 1994, American journal of hypertension.